TDMS No. 20201 - 03 Test Type: 26-WEEK Route: SKIN APPLICATION Species/Strain: MICE/TG.AC HEMI C Number: Lock Date: Cage Range: Date Range: Reasons For Removal: Removal Date Range: Treatment Groups: P04: NEOPLASMS BY INDIVIDUAL ANIMAL TEF TRANSGENICS (PECDF) CAS Number: 57117-31-4 Date Report Reqsted: 06/15/2006 Time Report Reqsted: 12:44:12 First Dose M/F: NA / 04/21/03 Lab: BAT C20201C 07/24/2004 ALL ALL ALL ALL Include ALL
21
Embed
TDMS No. P04: NEOPLASMS BY INDIVIDUAL ANIMAL Date …Date Report Reqsted: 06/15/2006 : Test Type: 26-WEEK : TEF TRANSGENICS (PECDF) Time Report Reqsted: 12:44:12 : Route:
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
TDMS No 20201 - 03
Test Type 26-WEEK
Route SKIN APPLICATION
SpeciesStrain MICETGAC HEMI
C Number
Lock Date
Cage Range
Date Range
Reasons For Removal
Removal Date Range
Treatment Groups
P04 NEOPLASMS BY INDIVIDUAL ANIMAL TEF TRANSGENICS (PECDF)
CAS Number 57117-31-4
Date Report Reqsted 06152006
Time Report Reqsted 124412
First Dose MF NA 042103
Lab BAT
C20201C
07242004
ALL
ALL
ALL
ALL
Include ALL
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 2
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 3
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20
MUSCULOSKELETAL SYSTEM NONE
NERVOUS SYSTEM NONE
RESPIRATORY SYSTEM
Lung
AlveolarBronchiolar Adenoma
Leukemia Erythrocytic
+ + + + + + + + + + + + + + + + + + + + 20
X 1 X 1
SPECIAL SENSES SYSTEM NONE
URINARY SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 4
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 5
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 6
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 2
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 3
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20
MUSCULOSKELETAL SYSTEM NONE
NERVOUS SYSTEM NONE
RESPIRATORY SYSTEM
Lung
AlveolarBronchiolar Adenoma
Leukemia Erythrocytic
+ + + + + + + + + + + + + + + + + + + + 20
X 1 X 1
SPECIAL SENSES SYSTEM NONE
URINARY SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 4
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 5
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 6
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 3
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20
MUSCULOSKELETAL SYSTEM NONE
NERVOUS SYSTEM NONE
RESPIRATORY SYSTEM
Lung
AlveolarBronchiolar Adenoma
Leukemia Erythrocytic
+ + + + + + + + + + + + + + + + + + + + 20
X 1 X 1
SPECIAL SENSES SYSTEM NONE
URINARY SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 4
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 5
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 6
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Skin Soa No Mass + + + + + + + + + + + + + + + + + + + + 20
MUSCULOSKELETAL SYSTEM NONE
NERVOUS SYSTEM NONE
RESPIRATORY SYSTEM
Lung
AlveolarBronchiolar Adenoma
Leukemia Erythrocytic
+ + + + + + + + + + + + + + + + + + + + 20
X 1 X 1
SPECIAL SENSES SYSTEM NONE
URINARY SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 4
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 5
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 6
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 5
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 6
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 6
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 7
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 8
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 9
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 10
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X 16
Skin Soa No Mass + + + + + + + + + + + + + + + + + 17
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 11
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 12
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 13
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X 1 Lymph Node
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Lumbar Leukemia Erythrocytic X 1
Mediastinal Squamous Cell Carcinoma X 1 Metastatic Skin
Renal Leukemia Erythrocytic X 1
Lymph Node Mandibular + + + 3
Leukemia Erythrocytic X 1
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + + 2
Spleen + + + + + + + + + + + + + + + + + + + + 20
Leukemia Erythrocytic X 1
Thymus + + + + + + + + + + + + + + + + + + + M 19
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 14
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X 19
Skin Soa No Mass + + + + + + + + + + + + + 13
MUSCULOSKELETAL SYSTEM NONE
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 15
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 16
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 17
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Spindle Cell Carcinoma Metastatic Skin X 1 Site Of Application
Squamous Cell Carcinoma Metastatic X X X 3 Skin
Thoracic Squamous Cell Carcinoma X 1 Metastatic Skin
Lymph Node Mandibular + + + 3
Squamous Cell Carcinoma Metastatic X 1 Skin
Lymph Node Mesenteric + 1
Spleen + + + + + + + + + + + + + + + + + + + + 20
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 18
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Squamous Cell Papilloma Multiple X X X X X X X X X X X X X X X X X X X X 20
Skin Soa No Mass + + + + + + + + + + + + 12
MUSCULOSKELETAL SYSTEM
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 19
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 20
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21
TDMS No 20201 -03 P0413
TGAC (FVBN) HEMIZYGOUS MICE FEMALE
END OF REPORT
TDMS No 20201 - 03 P04 NEOPLASMS BY INDIVIDUAL ANIMAL Date Report Reqsted 06152006
Test Type 26-WEEK TEF TRANSGENICS (PECDF) Time Report Reqsted 124412
Route SKIN APPLICATION CAS Number 57117-31-4 First Dose MF NA 042103
Total animals with tissue examined microscopically Total animals with tumor M Missing tissue + Tissue examined microscopically A Autolysis precludes evaluation x Lesion present BLANK Not examined microscopically I Insufficient tissue
Control data contained within this report was collected on study 20201-01 Page 21